Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Financings

Eledon Pharmaceuticals, Inc.

Financings

RaiseDate
Public offering of common stock and pre-funded warrants
Closed: US$57.5M raised · US$1.65 a share · Leerink Partners +2
Dealers: Leerink Partners (co-lead), Cantor (co-lead), LifeSci Capital (co-lead)
Use of proceeds: Advance tegoprubart programs in kidney transplantation, islet cell transplantation and xenotransplantation
Nov 14, 2025

Read by 6ix AI from the company's releases